首页> 外文期刊>Biomacromolecules >Designing Cell-Aggregating Peptides without Cytotoxicity
【24h】

Designing Cell-Aggregating Peptides without Cytotoxicity

机译:设计无细胞毒性的细胞聚集肽

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We have designed α-helical peptides de novo that can induce aggregation of various kinds of cells by focusing on physicochemical properties such as hydrophobicity, net charges, and amphipathicity. It is shown that peptide hydrophobicity is the key factor to determine capabilities for cell aggregation while peptide net charges contribute to nonspecific electrostatic interactions with cells. On the other hand, amphipathic peptides tend to exhibit cytotoxicity such as antimicrobial activity and hemolysis, which are competitive with cell-aggregation capabilities. Different from the cases of living cells, aggregation of artificial anionic liposomes appears to be mainly determined by electrostatic interactions. This discrepancy might be due to the complex structure of surfaces of cell membranes consisting of macromolecular chains such as peptidoglycans, polysaccharides, or glycocalyx, which coexist with lipid bilayers. Our design strategy would pave the way to design peptides that lead aggregation of living cells without cytotoxicity.
机译:我们设计了从头开始的α-螺旋肽,通过关注理化特性(例如疏水性,净电荷和两亲性)可以诱导各种细胞的聚集。结果表明,肽的疏水性是决定细胞聚集能力的关键因素,而肽的净电荷则有助于与细胞的非特异性静电相互作用。另一方面,两亲性肽倾向于表现出细胞毒性,例如抗微生物活性和溶血作用,与细胞聚集能力竞争。与活细胞的情况不同,人工阴离子脂质体的聚集似乎主要由静电相互作用决定。这种差异可能是由于与脂双层共存的由大分子链(例如肽聚糖,多糖或糖萼)组成的细胞膜表面的复杂结构所致。我们的设计策略将为设计可导致活细胞聚集而无细胞毒性的肽铺平道路。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号